## Business Plan: Aura of Intelligence for Dementia Care

## 1. Executive Summary

- Objective : Deliver a personalised AI system that assists individuals with dementia, their families, and caregivers.
- Vision : Enhance the quality of life, autonomy, and dignity of individuals with dementia through advanced AI and smart device integration.
- Mission : Create an adaptable AI solution that aligns with the evolving needs of its users and integrates emerging technological advancements.

## 2. Background

- Dementia Overview : Brief on dementia, its impact, and the need for personalised care.
- Tech in Dementia Care : The role of technology and AI in modern dementia care.

## 3. Product Overview: Aura of Intelligence

- Core Features :
- o Persona Mapping
- o Behaviour Modelling
- o Social Connection Facilitation
- o Future State Roadmap
- Unique Value Proposition : Explain the differentiation of Aura from other solutions.

## 4. Market Analysis

- Target Market : Early onset dementia patients (plus their families, caregivers)
- Market Size :
- o Australian Early Onset Dementia population is estimated to be 28,650 people
- o Australian total population of Dementia cases is estimated at over 400,000
- o USA Early Onset Dementia population is estimated to be 220,000 to 640,000
- o UK Early Onset Dementia population is estimated to be 70,800 people
- o In 2019, Dementia cost the global economy approximately 1.3 trillion USD
- o The total global estimate for Dementia is 55.2 million people x $23,796 USD
- o Annually there are over 10 million new diagnosed cases of Dementia globally
- Competitive Analysis : Overview of existing solutions and their gaps.
- o Companies (Pharmaceuticals, Biotech, and Technology):
- Eli Lilly and Company : Engaged in the development of drugs for Alzheimer's.
- Biogen : Known for its Alzheimer's drug, Aducanumab.
- Roche/Genentech : Working on dementia and Alzheimer's treatments.
- Merck & Co. : Conducts research on Alzheimer's drugs.
- Novartis : Engaged in Alzheimer's drug research.
- Pfizer : Previously involved in Alzheimer's research.
- Google/Alphabet's Calico Labs : Works on age-related diseases, including dementia.
- Apple : Their devices and software (like the Health app) have potential applications in dementia care, such as monitoring and data collection.

## o Non-Profit Organisations and Advocacy Groups:

- Alzheimer's Association : A leading voluntary health organisation in Alzheimer's care, support, and research.
- Alzheimer's Research UK : The UK's leading dementia research charity.
- Alzheimer's Society (UK) : Provides care, funds research, and advocates for policy on dementia.
- Alzheimer's Disease International (ADI) : An international federation of Alzheimer's organisations.
- Lewy Body Dementia Association : Focuses on Lewy body dementias.
- UsAgainstAlzheimer's : An advocacy organisation and network pushing for a cure.
- Dementia Australia : Represents people affected by dementia in Australia.
- Cure Alzheimer's Fund : Funds research for Alzheimer's disease.
- BrightFocus Foundation : Supports research on Alzheimer's, glaucoma, and macular degeneration.
- ACT on Alzheimer's : A collaboration of organisations and individuals working to prepare Minnesota for the impacts of Alzheimer's disease.

## o Research and Academic Institutions:

- The Alzheimer's Disease Neuroimaging Initiative (ADNI) : A large research initiative helping to define the progression of Alzheimer's disease.
- Banner Alzheimer's Institute : Engaged in research and offers patient care.
- The Knight Alzheimer's Disease Research Centre at Washington University : Conducts a range of Alzheimer's-related research.

This list is by no means exhaustive, but it gives an overview of the significant players in the field of dementia. Each country often has its national dementia and Alzheimer's association, and there are countless smaller organisations, research institutes, and companies worldwide working on the problem from various angles.

## 5. Marketing and Outreach

- Channels : How to reach the target audience.

- Partnerships : Collaborations with dementia care organisations and tech companies.

## 6. Implementation Strategy

- Development Timeline : Key milestones from MVP to full product launch.
- Feedback Loop : Involvement of early users for feedback and refinement.

## 7. Financial Projections

- Revenue Streams : Subscription model, partnership collaborations, etc.
- Cost Structure : Development, marketing, operations, and other overheads.
- Break-even Analysis : When the business becomes profitable.

## 8. Risks and Mitigation

- Technological Risks : Dependence on evolving tech, software glitches.
- Market Risks : Adoption rate, competition.
- Operational Risks : Data privacy, ethical concerns.

## 9. Ethical Considerations

- Data Privacy : Ensuring user data is protected and used responsibly.
- Consent : How consent is obtained and respected throughout the user's journey.
- Oversight and Accountability : Ensuring the AI acts in the best interest of the user.

## 10. Conclusion & Future Vision

- Short-term Goals : Immediate objectives for the next 1-2 years.
- Long-term Vision : How Aura plans to evolve and its potential impact on dementia care.

## 11. Appendix

- Case Studies : Real-world examples or hypothetical scenarios demonstrating Aura's impact.
- Technical Specifications : Details on the tech stack, AI algorithms, and device compatibility.
- Testimonials : Feedback from early users or stakeholders.

This outline provides a comprehensive structure to address all important aspects of your business plan. Each section can be expanded upon with detailed information, research findings, and projections.